EN 
ES 
Grant Opportunities
Find and apply to programs specifically for glomerular disease research.
NephCure – PARASOL Grant Program
NephCure announces the call for applications for its scientific grant program to support the PARASOL project. PARASOL is a collaborative international effort that aims to define the quantitative relationships between short-term changes in biomarkers (proteinuria and GFR) and long-term outcomes in order to support the use of alternative proteinuria-based endpoints as a basis for accelerated and traditional approval.
The PARASOL group will achieve this in 2024 by conducting a large-scale analysis of existing data from patients of all ages with FSGS who have participated in observational cohort studies, completed clinical trials, regional or national registries, or real-world data sets.
Eligibility: The program is open to all investigators or clinicians who oversee an existing cohort study, registry, or real-world data inclusive of substantial FSGS patient data meeting the dataset eligibility criteria defined by the PARASOL Data Analysis Team.
Funding: NephCure will award funds in accordance with anticipated costs per project to support high quality registries contributions to PARASOL. To protect the integrity of the PARASOL study and ensure regulatory compliance, applying registries must be reviewed and approved by the PARASOL Organizing Committee before submission of a proposal for funding from NephCure.
NephCure – NephCure Pilot Grant Program
NephCure announces the next call for applications for its scientific grant program to support investigator-initiated studies that employ NEPTUNE and/or CureGN resources to advance clinical and translational research in glomerular disease. The program is open to all scientists, whether a participant in the consortia or not. Proposed projects can include but are not limited to those that can be used to generate feasibility data to support advancement of promising future studies and projects to develop clinical assays, or protocols, or early phase clinical trials. NephCure will award up to $250,000 total cost for two projects to be paid out over the course of two years, after a competitive process to select the most meritorious project.
To protect the integrity of the overall NEPTUNE/CureGN studies, prioritize the utilization of resources for scientific advancement, ensure regulatory compliance and monitor participant burden, ancillary studies must be reviewed and approved by a joint CureGN or NEPTUNE Ancillary Study Review Committee and the CureGN and/or NEPTUNE Steering Committees. This process helps evaluate proposals for burden to NEPTUNE and/or CureGN Consortia, their study subjects, and their biosamples.
Current Partnerships
Building a better world for everyone affected by rare kidney disease takes help along the way. Our corporate partners play a critical part in powering our mission, helping fuel the revolution in research and care.
LEARN MORE
